Evolution of abiotic cubane chemistries in a nucleic acid aptamer allows selective recognition of a malaria biomarker
Author(s) -
YeeWai Cheung,
Pascal Röthlisberger,
Ariel Méchaly,
Patrick Weber,
Fabienne LeviAcobas,
Young Lo,
Alvin W. C. Wong,
Andrew B. Kinghorn,
Ahmed Haouz,
G. Paul Savage,
Marcel Hollenstein,
Julian A. Tanner
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2003267117
Subject(s) - aptamer , plasmodium falciparum , nucleic acid , cubane , biology , computational biology , molecular recognition , chemistry , biochemistry , malaria , genetics , crystal structure , crystallography , molecule , organic chemistry , immunology
Significance We report the identification of a cubane-modified aptamer (cubamer) against the malaria biomarkerPlasmodium vivax lactate dehydrogenase (PvLDH). The cubamer contains the benzene isostere cubane, which is entirely alien to biology. The crystal structure of the cubamer–protein complex reveals a binding mechanism involving the formation of an unprecedented cubane pocket and an unusual C–H⋅⋅⋅O hydrogen bond. Importantly, the cubamer is capable of distinguishing the PvLDH from thePlasmodium falciparum LDH despite a very high sequence homology, which is impossible for unmodified aptamers. Finally, we have used the cubamer to detect PvLDH in a mimetic clinical situation. This approach blending medicinal chemistry and Darwinian evolution can easily be extended to other nonnatural, exotic functional groups.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom